Adjusted probabilities of end points by donor groups in the CNI cohort
| End points . | MSD, % (95% CI) . | MUD, % (95% CI) . |
|---|---|---|
| OS at 5 years | 43 (42-45) | 44 (43-46) |
| DFS at 5 years | 37 (36-39) | 40 (38-41) |
| NRM at 5 years | 29 (28-31) | 32 (31-34) |
| Relapse at 5 years | 43 (41-45) | 37 (36-39) |
| Acute 2-4 GVHD at 6 months | 30 (29-31) | 35 (34-37) |
| Acute 3-4 GVHD at 6 months | 12 (11-13) | 12 (11-13) |
| Chronic GVHD at 12 months∗ | 37 (36-39) | 41 (39-42) |
| End points . | MSD, % (95% CI) . | MUD, % (95% CI) . |
|---|---|---|
| OS at 5 years | 43 (42-45) | 44 (43-46) |
| DFS at 5 years | 37 (36-39) | 40 (38-41) |
| NRM at 5 years | 29 (28-31) | 32 (31-34) |
| Relapse at 5 years | 43 (41-45) | 37 (36-39) |
| Acute 2-4 GVHD at 6 months | 30 (29-31) | 35 (34-37) |
| Acute 3-4 GVHD at 6 months | 12 (11-13) | 12 (11-13) |
| Chronic GVHD at 12 months∗ | 37 (36-39) | 41 (39-42) |
Moderate-severe chronic GVHD.